T-106 Papaverine 30 mg/mL Phentolamine 1 mg/mL Alprostadil 25 mcg/mL, Packaged as a) 5 mL Multi-Dose vial NDC 73198-0013-05; b) 10 mL Multi-Dose vial NDC 73198-0013-10, Rx Only, Olympia Pharmaceuticals, 6700 Conroy Rd., Ste. 155 Orlando, FL 32835

Recall Insight

This FDA Drug action (record #D-0910-2022) was formally reported on June 1, 2022, with the manufacturer initiating the action on May 9, 2022. It is classified under Moderate severity (Class II), with a current status of Completed. Olympia Compounding Pharmacy dba Olympia Pharmacy is listed as the recalling firm, operating out of Orlando, FL. Federal records indicate 3185 vials units are affected.

The documented reason for this recall is: Lack of assurance of sterility. Distribution data in the federal record shows the product reached: Distributed Nationwide in th USA, Puerto Rico and US Virgin Islands. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.

To put this record in context, PlainRecalls indexes 83,949 recalls across the FDA, CPSC, NHTSA and USDA FSIS going back to 1995. Within the same product category, the database holds 6 closely related recalls, of which 5 were also issued by FDA Drug. That clustering is a signal — repeated actions in a narrow category often indicate a systemic quality-control issue, a supplier-wide contamination, or a design defect that has propagated across product lines. This recall is roughly 4 years old; older recalls can remain relevant because many units enter resale, rental, and secondary-market channels where the original warning never reaches the end user. Always cross-check the recall number against the official agency page before relying on any summary.